Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. - Test2 - elhamkhani - TriplyDB

Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.

Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.

http://www.wikidata.org/entity/Q34550816

about

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma Synovial sarcoma of the spine: a case involving paraspinal muscle with extensive calcification and the surgical consideration in treatment Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma Synovial Sarcoma of the Head and Neck: A Single Institution Review.Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group.Molecular and clinicopathological findings in a tonsillar synovial sarcoma. A case study and review of the literature Primary pulmonary biphasic synovial sarcoma confirmed by molecular detection of a SYT-SSX2 fusion gene: report of 1 case Malignant inguinal monophasic synovial sarcoma: report of a case and review of the literature.Response to chemotherapy is not related to chromosome instability in synovial sarcoma.Synovial sarcoma: from genetics to genetic-based animal modeling Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors.The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas.The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.Emerging therapeutic targets for synovial sarcoma.Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report.Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?Synovial sarcoma in patients under 20 years of age: a multicenter study with a minimum follow-up of 10 years.Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer [Head and neck synovial sarcoma: a rare location: report of two cases].Resectable pediatric nonrhabdomyosarcoma soft tissue sarcoma: which patients benefit from adjuvant radiation therapy and how much?Distinct Clinical Characteristics of Unplanned Excision in Synovial Sarcoma.Imaging features of primary and metastatic extremity synovial sarcoma: a single institute experience of 78 patients.The role of genetic testing in soft tissue sarcoma.Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world.Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.Next generation sequencing in synovial sarcoma reveals novel gene mutations.Magnetic resonance imaging features of renal synovial sarcoma: a case report.Gene translocations in musculoskeletal neoplasms.Clinical relevance of molecular genetics to paediatric sarcomas The First Ever Reported Case of Primary Synovial Sarcoma of Scalp.Synergism of heat shock protein 90 and histone deacetylase inhibitors in synovial sarcoma.Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.The clinical implication of SS18-SSX fusion gene in synovial sarcoma.The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis Diagnostic and prognostic sarcoma signatures.Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma

P2860

Q24808685-4A4458D4-8EE4-49BE-965E-D5363351AAC2 Q26825344-B49BE01F-0998-4DA2-9A9D-9D1C94946F60 Q28271454-8492E29C-76DF-4EC7-88F8-E4B95D43BDA4 Q33809880-2C6D76C1-DAE1-481B-9D17-22A22E5FB52D Q33873982-67534364-383F-4629-AECF-82EC02E842F6 Q34072080-AF90B577-9D18-4C20-837E-E2E70AF55931 Q34102151-88C03521-CF34-4940-9667-5B1D841DD0F9 Q34372419-020E4775-47C7-44CF-829B-1E1DA40C1071 Q34395325-EC941BB7-FC39-4B5C-AAF8-1243C0F34A61 Q34593303-53EE4294-3897-4E5F-842C-7F115058ED1A Q34602033-84714715-57C4-45AB-8D1F-627B5CEC40C3 Q34609393-76C805A0-A0B5-454B-9ADB-82D12844CD4E Q34622557-5A50DA0F-DE58-4165-AE0E-ABB8D2234D9E Q34655297-1D2BB803-C05F-4BBA-A50A-190B5953C561 Q34657445-FBC62530-9CBD-4949-B99C-9986C95FA4F0 Q34660607-E2BDA133-5C2B-4922-A55F-AD68DD4E082D Q34663373-629F52CB-E536-4BF3-9643-8B81E77E6BCF Q34666948-F09ABA2A-511F-4937-9FEB-42F4AFA4B99F Q35061368-9B9698F4-CC14-4955-AB64-558791EE2328 Q35230631-EDA0F6DA-7192-46B5-B6EB-DC7F749DB3EF Q35400919-6AB3FC4E-5279-443A-AF3C-8D0A1596F638 Q35559881-812067E2-5F84-429C-AE7B-CA19DF03F3B7 Q35787598-48278113-244B-4788-B574-9F7DEC16B16D Q35864091-8E955216-5F2A-4BB0-AE62-9FB179D7FEEE Q35890300-802E254B-E287-499F-AD78-D9FB7A65503B Q36187189-9ABB70B7-9437-4615-B393-B53B86E3AD6F Q36344267-FF3C6C65-7CF2-4C81-A5C4-96FD28A8BD55 Q36344281-8C7CCC52-06A3-4411-8EC7-668DCED358DF Q36408355-1C25FF18-B261-40F2-A4FE-E765813E01F8 Q36544186-3E66CA96-2313-4FE7-8AEA-50A507C0EAC5 Q36573080-A476A9A8-8F78-4174-87BE-775128764235 Q36803632-B1F1A307-FBB3-4A6B-AF01-163753F39C39 Q36806186-678F7955-3A7D-4123-86EF-64C5388E8E62 Q37089234-3B95D31C-0191-4CA7-B73F-AA9CB5B55BE6 Q37138320-833B3FCF-67AC-4A8A-8D34-4DF1C3F2D0C5 Q37183461-B34990D5-EA51-4CBE-B461-FFEB94C40219 Q37235515-E5404A81-4F75-4CF5-A3FE-2F45608D6297 Q37239154-5AB558D2-F948-406A-AE22-1851474C2AD1 Q37335373-48C2D91D-B9DE-4550-BBBD-0B3ADEC2CCA4 Q37379626-41BBDF66-9988-4D0B-9D0A-F1A7A9288529

P2860

Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.

http://www.wikidata.org/entity/Q34550816

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@ast

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@en

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@nl

type

label

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@ast

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@en

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@nl

prefLabel

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@ast

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@en

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@nl

P1433

Q34550816-6A7A20A7-E18D-4AE0-9104-1C050F8972DC

P1476

Q34550816-72E0A038-3275-47B1-8989-CDE0B820DA5B

P2093

Q34550816-20D10F06-F8F2-46CF-B86A-D95B80148B80

Q34550816-35C8163E-D79A-446F-89B1-8DAED263D579

Q34550816-4D6F0868-B6E0-4B7A-894E-8C55D46F93FD

Q34550816-63F6D595-DC3C-4A59-AAD1-761D095B7E7B

Q34550816-932CA83D-BA2C-4C80-9474-30F9F4CBC796

Q34550816-93FAD447-6BC5-4E0F-BF98-B53E08B195B9

Q34550816-A6A77110-2E86-4B7F-8314-B228E44286E6

Q34550816-A98A5B63-AC3A-4462-A30C-0B8C25D982A9

Q34550816-B1701415-BD39-4A42-9AFD-023B57445EA1

Q34550816-CBFDD763-47B9-4FEB-B50D-7F76D6C60810

P304

Q34550816-9F737DAE-E295-4456-A420-EDB8DF8B2A14

P31

Q34550816-4B0BCADB-D21F-44F9-A3AF-427F50EB9EE5

P356

Q34550816-F02B369A-1AD9-46DB-B584-276F82AFB17B

P407

Q34550816-EB1A7FBF-CC0A-4986-B2A5-A184BD8DEC80

P433

Q34550816-4B4A0F6D-3102-4F73-A4C6-D659DEF8F758

P478

Q34550816-BFFE88F8-2E09-458B-A41C-07598ACD34DF

P577

Q34550816-E6D36E4C-9112-45CE-9D68-8EBA40174DB5

P698

Q34550816-708F3B45-3D83-45ED-9B5F-7A3D3D554E7D

P921

Q34550816-809A27C1-D825-449D-BF40-3BDF71D59969

P356

JCO.2004.11.093

P1433

Journal of Clinical Oncology

P1476

Histologic grade, but not SYT- ...... enter, retrospective analysis.

@en

P2093

Dominique Ranchère Vince

http://www.w3.org/2001/XMLSchema#string

Edouard Stauffer

http://www.w3.org/2001/XMLSchema#string

Françoise Bonichon

http://www.w3.org/2001/XMLSchema#string

Françoise Collin

http://www.w3.org/2001/XMLSchema#string

Gabrielle Gallagher

http://www.w3.org/2001/XMLSchema#string

Gernot Jundt

http://www.w3.org/2001/XMLSchema#string

Jean Benhattar

http://www.w3.org/2001/XMLSchema#string

Jean-Jacques Michels

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Coindre

http://www.w3.org/2001/XMLSchema#string

Louis Guillou

http://www.w3.org/2001/XMLSchema#string

P304

4040-4050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2004.11.093

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15364967

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial